Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations:  Biora, Cessation, Chimeric, Cocrystal, Galera, Huidagene, Ionctura, Mersana, Sosei, Sparx, X4.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Sibionics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: BMS, Coherus, Day One, Junshi, Nurexone, Oncoinvent, Phathom, Sellas.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Xenix.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Biosyngen, Calliditas, Genexine, Life Molecular, Sumitomo.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Calliditas, Eli Lilly, Everest, Genentech, Immunogen, Novartis, Roche and Santhera.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alivedx, Neurotrigger.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Altimmune, Bavarian Nordic, Biosyngen, Immunitybio, Lipocine, Mustang, Nrx, Nymox, Oncternal, Paxmedica, Pfizer, Tenaya, Valneva, Viiv.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cordance, Exatech.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akebia, Biomarin, Edesa, Genentech, Phaxiam, Samsung, Servier.